{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:49Z","timestamp":1761986569036,"version":"3.40.5"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:p>Angioedema (AE) is a reason for emergency care when it is severe. Care is difficult when the diagnostic is not known before the attack: mast cell (MC) or bradykinin (BK) mediated. One is very common but often benign, the other rare but potentially fatal. The French national reference center of angioedema (CREAK) provides emergency physicians with a hotline and a guideline to help them manage their patients. This study aimed to describe the clinical features of AE episodes prompting a call on the CREAK hotline and classify patients depending on the suspected cause of the AE. This is a retrospective study between March and August 2019. Each physician calling on the CREAK hotline was asked to fill a clinical description form for the AE emergency. Known patients of CREAK was excluded. Eighty four patients were included. Forty one (48.8%) in the angiotensin converting enzyme inhibitors induced acquired angioedema (ACEi-AAE), 39 (46.4%) in the mast cell induced angioedema, and 4 (4.8%) in the Bradykinin mediated angioedema. The mast cell induced angioedema patients have more history of hives (29.3%) than ACEi-AAE (2.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> = .0004). ACEi-AAE mainly affected the tongue (58.5% vs 25.6%, <jats:italic toggle=\"yes\">P<\/jats:italic> = .003) and larynx (29.3% vs 13%, <jats:italic toggle=\"yes\">P<\/jats:italic> = .001). In 65.5% of cases, the etiological diagnosis was not mentioned by the appellant, but made by the hotline. In 31% of cases, the hotline suggested the administration of a specific treatment not previously provided by the caller. All the doctors who called the hotline appreciate this tele-expertise especially in case of ACEi-AAE presumptions. In addition to providing rapid AE expertise, this service also allows to educate physicians in the management of AE irrespective of its origin.<\/jats:p>","DOI":"10.1097\/md.0000000000029513","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:02:55Z","timestamp":1660053775000},"page":"e29513","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Profile of serious angioedema requiring an urgent advice from a national reference call center"],"prefix":"10.1097","volume":"101","author":[{"given":"Nicolas","family":"Simon","sequence":"first","affiliation":[{"name":"National Reference Center for Angioedema (CREAK), Grenoble University Hospital (CHUGA), Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Bocquet","sequence":"additional","affiliation":[{"name":"National Reference Center for Angioedema (CREAK), Grenoble University Hospital (CHUGA), Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5774-8429","authenticated-orcid":false,"given":"Isabelle","family":"Boccon-Gibod","sequence":"additional","affiliation":[{"name":"National Reference Center for Angioedema (CREAK), Grenoble University Hospital (CHUGA), Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8245-4767","authenticated-orcid":false,"given":"Laurence","family":"Bouillet","sequence":"additional","affiliation":[{"name":"National Reference Center for Angioedema (CREAK), Grenoble University Hospital (CHUGA), Grenoble, France"},{"name":"Grenoble Alpes University (UGA), France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2500\/aap.2010.31.3403","article-title":"The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007","volume":"31","author":"Zilberberg","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"R2-20250504","first-page":"455","article-title":"Drug-induced angioedema: experience of Italian emergency departments","volume":"9","author":"Bertazzoni","year":"2014","journal-title":"Intern Emerg Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2500\/aap.2014.35.3787","article-title":"Prognostic factors in outcome of angioedema in the emergency department","volume":"35","author":"Felder","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-016-8541-z","article-title":"Angioedema phenotypes: disease expression and classification","volume":"51","author":"Wu","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/JAA.S205709","article-title":"Idiopathic angioedema: current challenges","volume":"13","author":"Belb\u00e9zier","year":"2020","journal-title":"J Asthma Allergy"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2012.12.017","article-title":"Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema","volume":"34","author":"Nosbaum","year":"2013","journal-title":"Rev Med Interne"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","article-title":"Meta-analysis of randomized trials of angioedema as an adverse event of renin\u2013angiotensin system inhibitors","volume":"110","author":"Makani","year":"2012","journal-title":"Am J Cardiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cea.13297","article-title":"Bradykinin mechanism is the main responsible for death by isolated asphyxiating angioedema in France","volume":"49","author":"Crochet","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clincial studies of sudden upper airway obstructionin aptients with hereditary angioedema due to C1 esterase Inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Int Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1503\/cmaj.060535","article-title":"Angioedema without urticaria: a large clinical survey","volume":"175","author":"Zingale","year":"2003","journal-title":"Can Med Ass J"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/joim.12304","article-title":"Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients","volume":"277","author":"Mansi","year":"2015","journal-title":"J Intern Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1684\/ejd.2014.2276","article-title":"Recurrent angioedema: diagnosis strategy and biological aspects","volume":"24","author":"Bouillet","year":"2014","journal-title":"Eur J Dermatol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/cei.12789","article-title":"Idiopathic histaminergic angioedema without wheals: a case series of 31 patients","volume":"185","author":"Faisant","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e1939","DOI":"10.1097\/MD.0000000000001939","article-title":"Angioedema related to angiotensin-converting enzyme inhibitors: attack severity, treatment, and hospital admission in a prospective multicenter study","volume":"94","author":"Javaud","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jaip.2017.07.039","article-title":"Icatibant for ACE-inhibitor angioedema, an opportunity to treat the patients?","volume":"5","author":"Javaud","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11739-015-1205-9","article-title":"Treatment of ACEI-related angioedema with icatibant: a case series","volume":"10","author":"Bova","year":"2015","journal-title":"Intern Emerg Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:28:27Z","timestamp":1746332907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":16,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029513","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}